Safety Guardrails and Who Should Avoid Fasting on GLP-1 Patients with Type 1 or Type 2 diabetes, a history of eating disorders, cardiovascular disease, or those taking additional glucose-lowering medications should consult their provider before any fasting protocol on GLP-1 therapy
We have seen that this repeatedly in all our prior studies supplementing GlyNAC, including this trial. One of the intriguing questions from this trial is why so many improvements occur toward promoting health
To maximize the benefits of tirzepatide, consider it part of a comprehensive lifestyle change that includes a healthy diet, regular physical activity, and ongoing medical guidance
Nausea, vomiting, diarrhea, decreased appetite, and mild injection site reactions
Due to this buffering effect on stomach pH, regenerate is recommended to be taken on an empty stomach